New Combination Therapy For Advanced Kidney Cancer
Combination of an angiogenesis inhibitor and an immunotherapy agent has shown promise in treating advanced kidney cancer with no unexpected adverse effects in an early-phase clinical trial in patients who have not received prior treatment.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer